Organic Letters
ORCID
Letter
(b) Bebernitz, G. R.; Aicher, T. D.; Stanton, J. L.; Gao, J.; Shetty, S.
S.; Knorr, D. C.; Strohschein, R. J.; Tan, J.; Brand, L. J.; Liu, C.;
Wang, W. H.; Vinluan, C. C.; Kaplan, E. L.; Dragland, C. J.;
DelGrande, D.; Islam, A.; Lozito, R. J.; Liu, X.; Maniara, W. M.;
Mann, W. R. J. Med. Chem. 2000, 43, 2248. (c) Berg, S.; Bergh, M.;
Present Address
Hellberg, S.; Ho
S.; Weigelt, T.; Ormo
̈
gdin, K.; Lo-Alfredsson, Y.; So
̈
derman, P.; von Berg,
, M.; Xue, Y.; Tucker, J.; Neelissen, J.; Jerning,
̈
E.; Nilsson, Y.; Bhat, R. J. Med. Chem. 2012, 55, 9107. (d) Harris, P.
A.; Cheung, M.; Hunter, R. N.; Brown, M. L.; Veal, J. M.; Nolte, R.
T.; Wang, L.; Liu, W.; Crosby, R. M.; Johnson, J. H.; Epperly, A. H.;
Kumar, R.; Luttrell, D. K.; Stafford, J. A. J. Med. Chem. 2005, 48,
610.
11) For an example of base-catalyzed activation of sulfonyl
fluorides, see: Gembus, V.; Marsais, F.; Levacher, V. Synlett 2008,
008, 1463.
12) For representation of Lewis acid complexation with sulfonyl
compounds, see: (a) Qi, C.; Hasenmaile, F.; Gandon, V.; Lebœuf, D.
ACS Catal. 2018, 8, 1734. (b) Peyronneau, M.; Roques, N.;
Mazieres, S.; Le Roux, C. Synlett 2003, 5, 0631.
(13) Begouin, J.-M.; Niggemann, M. Chem. - Eur. J. 2013, 19, 8030.
14) There is also potential for interaction of the Lewis acid with
the amine nucleophile. For an example of Ca(NTf ) participating in
coordination of sulfonyl oxygens and NH bonds with the assistance
of an alcoholic solvent, see: Lebœuf, D.; Gandon, V. Synthesis 2017,
9, 1500.
15) Lebœuf, D.; Gandon, V. Synthesis 2017, 49, 1500 and
references cited therein.
16) Ramgren, S. D.; Hie, L.; Ye, Y.; Garg, N. K. Org. Lett. 2013,
§(
L.C.) Ideaya Biosciences, 7000 Shoreline Ct, Suite 305,
South San Francisco, CA 94080.
Author Contributions
1
(
This work was performed in collaboration between the Ball
laboratory at Pomona College and Pfizer.
Notes
2
(
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
N.D.B. thanks Pomona College for start-up funds. Addition-
ally, acknowledgment is made to the Donors of the American
Chemical Society Petroleum Research Fund for support
(
2
2
(
544180-UNI). S.M.E., R.W.F., S.C.K., M.R., and C.P.W.
thank the Pomona SURF program and the Pomona
Department of Chemistry for their funding. C.P.W. and
N.D.B. thank the ACS Scholars Program. C.P.W., N.D.B. and
C.W.A. thank the Beckman Scholars Program. The authors
also thank Mona Shahgholi and Nassem Torian (Caltech) for
the HRMS analyses, Ivan Samardjiev (Pfizer) for X-ray
crystallography, and Patrick Mullins (Pfizer) and Christopher
Helal (Pfizer) for critical review of the manuscript.
4
(
(
15, 3950.
18) Tribby, A. L.; Rodríguez, I.; Shariffudin, S.; Ball, N. D. J. Org.
Chem. 2017, 82, 2294.
19) Chappie, T. A.; Henderson, J. L.; Young, J. M.; Wager, T. T.;
Kormos, B. L.; Patel, N. C.; Sciabola, S.; Tuttle, J. B.; Verhoest, P.
R.; Tucker, J. W. (Pfizer, Inc., USA). Preparation of 6,7,8,9-
tetrahydro-5H-pyrido[2,3-d]azepine compounds as selective dopa-
mine D3 ligands. PCT Int. Appl. WO 2017122116A1 20170720,
(
(
REFERENCES
■
(
2
1) McGrath, N. A.; Brichacek, M.; Njardarson, J. T. J. Chem. Educ.
010, 87, 1348.
(
2) Devendar, P.; Yang, G.-F. Top. Curr. Chem. 2017, 375, 1.
(
3) (a) Wright, S. W.; Hallstrom, K. N. J. Org. Chem. 2006, 71,
2
017.
1080. (b) Bahrami, K.; Khodaei, M. M.; Abbasi, J. Tetrahedron 2012,
68, 5095. (c) Goldberg, F. W.; Kettle, J. G.; Kogej, T.; Perry, M. W.
D.; Tomkinson, N. P. Drug Discovery Today 2015, 20, 11.
4) (a) Dong, J.; Krasnova, L.; Finn, M. G.; Sharpless, K. B. Angew.
Chem., Int. Ed. 2014, 53, 9430 and references cited therein.
b) Bogolubsky, A. V.; Moroz, Y. S.; Mykhailiuk, P. K.; Pipko, S.
E.; Konovets, A. I.; Sadkova, I. V.; Tolmachev, A. ACS Comb. Sci.
014, 16, 192.
5) (a) Kiang, T.; Zare, R. N. J. Chem. Soc., Chem. Commun. 1980,
4, 1228. (b) Wray, K. L.; Feldman, E. V. J. Chem. Phys. 1971, 54,
445.
6) (a) Bertrand, M. P. Org. Prep. Proced. Int. 1994, 26, 257.
b) Chatgilialoglu, C. Sulfonyl Radicals. In Sulphones and Sulfoxides;
(
(
2
(
2
3
(
(
Patai, S., Rappoport, Z., Stirling, C., Eds.; John Wiley & Sons, Ltd:
Chichester, 1988; pp 1089−1113.
(
7) (a) Baker, B. R.; Lourens, G. J. J. Med. Chem. 1967, 10, 1113.
(
b) Ciuffarin, E.; Senatore, L.; Isola, M. J. Chem. Soc., Perkin Trans. 2
1
972, 4, 468. (c) Mukherjee, H.; Debreczeni, J.; Breed, J.; Tentarelli,
S.; Aquila, B.; Dowling, J. E.; Whitty, A.; Grimster, N. P. Org. Biomol.
Chem. 2017, 15, 9685. (d) Huang, J. L.; Nagy, A.; Ivleva, V. B.;
Blackstock, D.; Arnold, F.; Cai, C. X. Anal. Chem. 2018, 90, 4293.
(
e) Kice, J. L.; Lunney, E. A. J. Org. Chem. 1975, 40, 2125.
(
8) (a) Narayanan, A.; Jones, L. H. Chem. Sci. 2015, 6, 2650 and
references therein. (b) Zhao, Q.; Ouyang, X.; Wan, X.; Gajiwala, K.
S.; Kath, J. C.; Jones, L. H.; Burlingame, A. L.; Taunton, J. J. Am.
Chem. Soc. 2017, 139, 680.
(
9) (a) Zelli, R.; Tommasone, S.; Dumy, P.; Marra, A.; Dondoni, A.
Eur. J. Org. Chem. 2016, 2016, 5102. (b) Toulgoat, F.; Langlois, B.
R.; Medebielle, M.; Sanchez, J.-Y. J. Org. Chem. 2008, 73, 5613.
10) (a) Empfield, J. R.; Mayhugh, D.; Ohnmacht, C. J.; Frank, C.
A.; Grant, T.; Li, J. Bioorg. Med. Chem. Lett. 1997, 7, 775.
́
(
E
Org. Lett. XXXX, XXX, XXX−XXX